Latest news
Dash Bio Raises $30M in Series A Funding to Develop Automated Bioanalysis Platform for Drug Discovery - AI InsiderAI Insider · Tue, 04 Aug 2026 11:52:11 GMTDASH Looks 9.5% Undervalued on GF Value™ Amid AI Security Probe - GuruFocusGuruFocus · Fri, 31 Jul 2026 15:41:52 GMTDoorDash CEO Says AI Coding Is Not Enough for Engineering Productivity - businessinsider.combusinessinsider.com · Tue, 28 Jul 2026 07:00:00 GMT